Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Familial Aggregation of Aortic Valvular Stenosis: A Nationwide Study of Sibling Risk.

Martinsson A, Li X, Zöller B, Andell P, Andersson C, Sundquist K, Smith JG.

Circ Cardiovasc Genet. 2017 Dec;10(6). pii: e001742. doi: 10.1161/CIRCGENETICS.117.001742.

PMID:
29242201
2.

Lipoprotein(a) Associated Molecules are Prominent Components in Plasma and Valve Leaflets in Calcific Aortic Valve Stenosis.

Torzewski M, Ravandi A, Yeang C, Edel A, Bhindi R, Kath S, Twardowski L, Schmid J, Yang X, Franke UFW, Witztum JL, Tsimikas S.

JACC Basic Transl Sci. 2017 Jun;2(3):229-240. doi: 10.1016/j.jacbts.2017.02.004. Epub 2017 Jun 26.

3.

Is there evidence for statins in the treatment of aortic valve stenosis?

Akin I, Nienaber CA.

World J Cardiol. 2017 Aug 26;9(8):667-672. doi: 10.4330/wjc.v9.i8.667. Review.

4.
5.

Valve Calcification in Aortic Stenosis: Etiology and Diagnostic Imaging Techniques.

Izquierdo-Gómez MM, Hernández-Betancor I, García-Niebla J, Marí-López B, Laynez-Cerdeña I, Lacalzada-Almeida J.

Biomed Res Int. 2017;2017:5178631. doi: 10.1155/2017/5178631. Epub 2017 Jul 24. Review.

6.

Premature Valvular Heart Disease in Homozygous Familial Hypercholesterolemia.

Fahed AC, Shibbani K, Andary RR, Arabi MT, Habib RH, Nguyen DD, Haddad FF, Moubarak E, Nemer G, Azar ST, Bitar FF.

Cholesterol. 2017;2017:3685265. doi: 10.1155/2017/3685265. Epub 2017 Jul 6.

7.

Oxidized Phospholipids and Risk of Calcific Aortic Valve Disease: The Copenhagen General Population Study.

Kamstrup PR, Hung MY, Witztum JL, Tsimikas S, Nordestgaard BG.

Arterioscler Thromb Vasc Biol. 2017 Aug;37(8):1570-1578. doi: 10.1161/ATVBAHA.116.308761. Epub 2017 Jun 1.

PMID:
28572160
8.

Traditional Cardiovascular Risk Factors and Their Relation to Future Surgery for Valvular Heart Disease or Ascending Aortic Disease: A Case-Referent Study.

Ljungberg J, Johansson B, Engström KG, Albertsson E, Holmer P, Norberg M, Bergdahl IA, Söderberg S.

J Am Heart Assoc. 2017 May 5;6(5). pii: e005133. doi: 10.1161/JAHA.116.005133.

9.

Myocardial Oxygen Consumption and Efficiency in Aortic Valve Stenosis Patients With and Without Heart Failure.

Hansson NH, Sörensen J, Harms HJ, Kim WY, Nielsen R, Tolbod LP, Frøkiær J, Bouchelouche K, Dodt KK, Sihm I, Poulsen SH, Wiggers H.

J Am Heart Assoc. 2017 Feb 6;6(2). pii: e004810. doi: 10.1161/JAHA.116.004810.

10.

Biomarkers of Calcific Aortic Valve Disease.

Small A, Kiss D, Giri J, Anwaruddin S, Siddiqi H, Guerraty M, Chirinos JA, Ferrari G, Rader DJ.

Arterioscler Thromb Vasc Biol. 2017 Apr;37(4):623-632. doi: 10.1161/ATVBAHA.116.308615. Epub 2017 Feb 2. Review.

PMID:
28153876
11.

Interleukin-37 suppresses the osteogenic responses of human aortic valve interstitial cells in vitro and alleviates valve lesions in mice.

Zeng Q, Song R, Fullerton DA, Ao L, Zhai Y, Li S, Ballak DB, Cleveland JC Jr, Reece TB, McKinsey TA, Xu D, Dinarello CA, Meng X.

Proc Natl Acad Sci U S A. 2017 Feb 14;114(7):1631-1636. doi: 10.1073/pnas.1619667114. Epub 2017 Jan 30.

12.

Risk factor profile of calcific aortic stenosis.

Sathyamurthy I, Alex S, Kirubakaran K, Sengottuvelu G, Srinivasan KN.

Indian Heart J. 2016 Nov - Dec;68(6):828-831. doi: 10.1016/j.ihj.2016.04.007. Epub 2016 Apr 28.

13.

Integrated microRNA and messenger RNA analysis in aortic stenosis.

Coffey S, Williams MJ, Phillips LV, Galvin IF, Bunton RW, Jones GT.

Sci Rep. 2016 Nov 23;6:36904. doi: 10.1038/srep36904.

14.

Role for Galectin-3 in Calcific Aortic Valve Stenosis.

Sádaba JR, Martínez-Martínez E, Arrieta V, Álvarez V, Fernández-Celis A, Ibarrola J, Melero A, Rossignol P, Cachofeiro V, López-Andrés N.

J Am Heart Assoc. 2016 Nov 4;5(11). pii: e004360.

15.

Heart Valve Biomechanics and Underlying Mechanobiology.

Ayoub S, Ferrari G, Gorman RC, Gorman JH, Schoen FJ, Sacks MS.

Compr Physiol. 2016 Sep 15;6(4):1743-1780. doi: 10.1002/cphy.c150048. Review.

16.

Valvular heart disease in older adults: seeking an ounce of prevention.

Shah AM, Solomon SD.

Eur Heart J. 2016 Dec 14;37(47):3523-3524. doi: 10.1093/eurheartj/ehw354. Epub 2016 Sep 1. No abstract available.

17.

Aortic stenosis: insights on pathogenesis and clinical implications.

Carità P, Coppola G, Novo G, Caccamo G, Guglielmo M, Balasus F, Novo S, Castrovinci S, Moscarelli M, Fattouch K, Corrado E.

J Geriatr Cardiol. 2016 Sep;13(6):489-98. doi: 10.11909/j.issn.1671-5411.2016.06.001.

18.

Histopathological assessment of calcification and inflammation of calcific aortic valves from patients with and without diabetes mellitus.

Mosch J, Gleissner CA, Body S, Aikawa E.

Histol Histopathol. 2017 Mar;32(3):293-306. doi: 10.14670/HH-11-797. Epub 2016 Jun 29.

19.

Cadherin-11 Overexpression Induces Extracellular Matrix Remodeling and Calcification in Mature Aortic Valves.

Sung DC, Bowen CJ, Vaidya KA, Zhou J, Chapurin N, Recknagel A, Zhou B, Chen J, Kotlikoff M, Butcher JT.

Arterioscler Thromb Vasc Biol. 2016 Aug;36(8):1627-37. doi: 10.1161/ATVBAHA.116.307812. Epub 2016 Jun 16.

20.

Proprotein convertase subtilisin/kexin type 9 levels and aortic valve calcification: A prospective, cross sectional study.

Wang WG, He YF, Chen YL, Zhao FM, Song YQ, Zhang H, Ma YH, Guan X, Zhang WY, Chen XL, Liu C, Cong HL.

J Int Med Res. 2016 Aug;44(4):865-74. doi: 10.1177/0300060516648030. Epub 2016 Jun 8.

Supplemental Content

Support Center